UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
------------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
------------------------
Date of Report (Date of earliest event reported): September 18, 2003
IMPAX LABORATORIES, INC.
----------------------------------------------------------------
(Exact name of Registrant as specified in its charter)
Delaware 0-27354 65-0403311
------------------------------- ----------------- ----------------------
(State or other jurisdiction of (Commission (I.R.S. Employer
incorporation or organization) File Number) Identification Number)
30381 Huntwood Avenue
Hayward, CA 94544
------------------------------------------------------------
(Address of principal executive offices, including zip code)
Registrant's telephone number, including area code: (510) 476-2000
------------------------
Item 4. Change in Registrant's Certifying Accountant
(a) Previous independent accountants
(i) On September 18, 2003, Impax Laboratories, Inc. (the
"Company") dismissed PricewaterhouseCoopers LLP as
its independent accountants. The Company's Audit
Committee made and approved the decision to change
independent accountants.
(ii) The reports of PricewaterhouseCoopers LLP on the
Company's financial statements for the past two
fiscal years contained no adverse opinion or
disclaimer of opinion and were not qualified or
modified as to uncertainty, audit scope or accounting
principle.
(iii) In connection with its audits for the two most recent
fiscal years and through September 18, 2003, there
have been no disagreements with
PricewaterhouseCoopers LLP on any matter of
accounting principles or practices, financial
statement disclosure, or auditing scope or procedure,
which disagreements, if not resolved to the
satisfaction of PricewaterhouseCoopers LLP, would
have caused them to make reference thereto in their
report on the financial statements for such years.
(iv) During the two most recent fiscal years and through
September 18, 2003, there have been no reportable
events (as defined in Regulation S-K Item 304
(a)(1)(v)).
(v) The Company has requested that PricewaterhouseCoopers
LLP furnish it with a letter addressed to the SEC
stating whether or not it agrees with the above
statements. A copy of such letter, dated September
25, 2003, is filed as Exhibit 16.1 to this Form 8-K.
(b) New independent accountants
The Company's Audit Committee has received proposals from and
interviewed five national accounting firms to serve as the
Company's new independent accountants. The Audit Committee
expects to complete the selection process within the next
week.
Item 7. Financial Statements and Exhibits.
(a) Financial statements of businesses acquired.
None.
(b) Pro-forma financial information.
None.
(c) Exhibits.
S-K Exhibit
Number Description
- ----------- -----------
16.1 Letter regarding change in certifying accountant.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Impax Laboratories, Inc.
Date: September 25, 2003
By: /s/ Cornel C. Spiegler
------------------------
Cornel C. Spiegler
Chief Financial Officer